Pharma-as-Defensive Rotation Claim Lacks Data Backing, Source Is Niche

CEO commentary from mid-tier firm flags pharma rotation during market upmove, but cites no flow data, index, or timeframe — treat as attributed opinion only.

bt-corporate · 6/28/2026, 10:48:06 AM · Ask about this →